ESP Pharma Overview

  • Founded
  • 2000

  • Status
  • Acquired/​Merged

  • Employees
  • 80

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $486M

ESP Pharma General Information


Developer of specialty pharmaceutical products designed to enhance the quality of therapeutics available to healthcare professionals. The company's specialty pharmaceutical products include therapeutics for high blood pressure and angina and late-stage development specialty drugs for bone marrow transplants, enabling patients to achieve improved outcomes in the acute-care setting.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 2035 Lincoln Highway
  • Suite 2150
  • Edison, NJ 08817
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ESP Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 24-Mar-2005 $486M 0000 00000 Completed Profitable
3. Debt - General 08-Oct-2003 0000 0000 Completed Profitable
2. Early Stage VC (Series B) 16-Apr-2003 $28M Completed Profitable
1. Early Stage VC (Series A) 01-Apr-2002 $28M $28M Completed Profitable
To view ESP Pharma’s complete valuation and funding history, request access »

ESP Pharma Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ESP Pharma Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alta Partners Venture Capital Minority 000 0000 000000 0
Apax Partners PE/Buyout Minority 000 0000 000000 0
Cressey & Company PE/Buyout Minority 000 0000 000000 0
Domain Associates Venture Capital Minority 000 0000 000000 0
ESP Equity Partners PE/Buyout Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »